Research programme: influenza virus vaccines - RedbiotecAlternative Names: Influenza VLPs - Redbiotec; RBT 101; RBT 102; RBT 103; RBT 104
Latest Information Update: 07 Nov 2013
At a glance
- Originator Redbiotec
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Influenza virus infections